Atlas Trials

Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

Clinical trial NCT06817265 · RECRUITING

Trial details

NCT number
NCT06817265
Sponsor
Beletalent (Zhuhai) Pharmaceutical Co., Ltd
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Non-Proliferative Diabetic Retinopathy
Start date
2025-04-29
Primary completion
2026-08-30
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.